Primer pair for quantitatively detecting size distribution of DNA (deoxyribonucleic acid) fragments of CHO (Chinese hamster ovary) cells and application thereof

By using real-time fluorescence quantitative PCR technology of specific primer pairs and probes in CHO cell DNA detection, the problem of difficult detection of DNA fragment size distribution in CHO cell is solved, and rapid and sensitive DNA fragment analysis is achieved, reducing the biological products Pathogenic risk simplifies the detection process.

CN119082274APending Publication Date: 2024-12-06YEASEN BIOTECHNOLOGY (SHANGHAI) CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411435993.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-15
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The prior art is difficult to effectively detect and analyze the size distribution of residual DNA fragments in CHO cells, making it difficult to control the potential pathogenic risks in biological products, and the detection methods are complex and time-consuming.

Method used

Provide a primer pair for quantitatively detecting the size distribution of DNA fragments in CHO cells. Combined with real-time fluorescence quantitative PCR technology, the size distribution of DNA fragments in CHO cells can be quickly and easily analyzed, including different lengths, through specific primer pairs and probes. amplified products for product quality control.

Benefits of technology

It realizes rapid and sensitive detection of the size of DNA fragments in CHO cells, can distinguish DNA fragments of different lengths, reduces the risk of pathogenicity of DNA residues in CHO cells in biological products, is easy to operate, the quantitative limit is 3fg/μL, and has strong specificity , able to distinguish interfering DNA.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119082274A_ABST
    Figure CN119082274A_ABST
Patent Text Reader

Abstract

The invention provides a primer pair for quantitatively detecting the size distribution of DNA (deoxyribonucleic acid) fragments of CHO (Chinese hamster ovary) cells, which at least comprises one group of primer pairs described as follows: a forward primer and a reverse primer in each primer pair are respectively and specifically combined with a section as shown in SEQ ID NO: 1, and the length of an amplification product of one group of primer pair is less than 100bp; the length of the amplification product of one group of primer pair is 100-199bp, the length of the amplification product of the other group of primer pair is 200-500bp, and the length of the amplification product of the other group of primer pair is more than 500bp. The method can be used for analyzing the CHO residual DNA fragment in the biological product, and is beneficial to improving the process and improving the product quality. The PCR detection method using the primer pair is simple, convenient and rapid to operate, and only 3h is needed for obtaining a detection result from a sample; the sensitivity is high, and the quantitation limit is 3fg / mu L; the specificity is high, and interference DNA (deoxyribonucleic acid) such as MDCK (madin-darby canine kidney), E.coli and the like can be distinguished. The primer pair combination can be used for quantitatively detecting the size distribution condition of CHO residual DNA fragments in biological products.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The patent of this invention relates to a primer pair for quantitatively detecting the size distribution of CHO cell DNA fragments and its application, belonging to the field of biological detection technology. Background Art

[0002] Among the biological drugs on the market and in clinical trials, 70% come from mammalian cell expression systems, among which the mammalian CHO cell line is currently the most widely used host cell for expressing and preparing biological products, and will continue to be the main host cell for producing biological products in recent years. In the preparation process of biological products (such as vaccines, antibody drugs, gene drugs, etc.), serial cell lines are mostly used for production. Strict purification processes can remove some of the host cell DNA fragments, but there may still be residual impurities in the product. These residual host cell DNA may transmit tumor or virus-related genes, which is potentially dangerous. The third part of the 2020 edition of the "Pharmacopoeia of the People's Republic of China" stipulates that the residual DNA of Conbercept is ≤30pg / mg, and the residual DNA of recombinant hepatitis B vaccine (CHO cells) should not exceed 10pg / dose. Therefore, the CHO host cell DNA detection project is one of the important quality inspection indicators in the production process of biological products.

[0003] Relevant studies have shown that the size of genes is generally above 200bp, so residual DNA fragments larger than 200bp may have certain pathogenicity, and the larger the residual DNA fragments, the higher the risk level of biological products. Therefore, regulatory agencies in various countries have put forward strict requirements for it. The U.S. Food and Drug Administration (FDA) clearly stated in its guidance document on the production of new human gene therapy products that the fragments of HCD (host cell DNA) should be less than 200bp; in May 2022, the "Technical Guidelines for Pharmaceutical Research and Evaluation of In Vivo Gene Therapy Products (Trial)" issued by the Drug Review Center (CDE) of the State Food and Drug Administration also clearly stated that the amount of DNA residues and the size of residual fragments need to be controlled, and it is recommended to control the size of residual DNA fragments to less than 200bp as much as possible. Therefore, quantitative detection of the use of CHO host cells to express antibodies and recombinant proteins, as well as the distribution of residual DNA fragments of CHO host cells during protein purification, is conducive to better quality testing of products, thereby reducing the pathogenicity of residual CHO host cell DNA fragments in biological products.

[0004] At present, the main method for analyzing residual host cell DNA fragments on the market is the capillary electrophoresis method. Researchers have developed a method based on capillary gel electrophoresis and sensitive laser induced fluorescence (CGE-LIF) to detect the size of residual DNA molecules, which can detect the size of residual DNA in biological products. Experiments have shown that the size of most host cell residual DNA fragments is 50 to 2000 bp. In addition to the capillary electrophoresis method, there are also kits on the market that use qPCR to detect DNA fragments related to production cells in biological products. Compared with CGE-LIF, it is simpler to operate and less time-consuming.

[0005] Since domestic and foreign regulatory agencies have strong concerns about the residual amount of host cell DNA and the size distribution of residual DNA fragments in biological products, there is an urgent need for the detection and analysis of the residual amount and size of residual DNA fragments in CHO cells, but no relevant reports have been seen. Summary of the invention

[0006] The invention provides a primer pair for quantitatively detecting the size distribution of CHO cell DNA fragments.

[0007] The technical solution adopted by the present invention is:

[0008] A primer pair for quantitatively detecting the size distribution of CHO cell DNA fragments, comprising at least one set of primer pairs described below: the forward primer and the reverse primer in each primer pair specifically bind to the segment shown in SEQ ID NO: 1, respectively, and the length of the amplification product of one set of primer pairs is less than 100 bp, the length of the amplification product of one set of primer pairs is 100-199 bp, the length of the amplification product of one set of primer pairs is 200-500 bp, and the length of the amplification product of one set of primer pairs is more than 500 bp.

[0009] Preferably, the primer pair refers to the first primer pair, the second primer pair, the third primer pair or the fourth primer pair;

[0010] The forward primer of the first primer pair binds to positions 113-156 of the sequence shown in SEQ ID NO: 1; the reverse primer binds to positions 184-221 of the sequence shown in SEQ ID NO: 1, and the length of the amplified product of the primer pair is 90-98 bp;

[0011] The forward primer of the second primer pair binds to positions 101-156 of the sequence shown in SEQ ID NO: 1; the reverse primer binds to positions 184-221 of the sequence shown in SEQ ID NO: 1, and the length of the amplified product of the primer pair is 105-120 bp;

[0012] The forward primer of the third primer pair binds to positions 101-156 of the sequence shown in SEQ ID NO: 1; the reverse primer binds to positions 282-320 of the sequence shown in SEQ ID NO: 1, and the length of the amplification product of the primer pair is 200-220 bp;

[0013] The forward primer of the fourth primer pair binds to positions 37-153 of the sequence shown in SEQ ID NO: 1; the reverse primer binds to positions 526-638 of the sequence shown in SEQ ID NO: 1, and the length of the amplified product of the primer pair is 500-557 bp.

[0014] Preferably, the first primer pair includes a forward primer as shown in SEQ ID NO: 3 and a reverse primer as shown in SEQ ID NO: 7, and the length of the amplified product is 92 bp;

[0015] The second primer pair includes a forward primer shown in SEQ ID NO: 2 and a reverse primer shown in SEQ ID NO: 8, and the length of the amplified product is 115 bp;

[0016] The third primer pair includes a forward primer shown in SEQ ID NO: 2 and a reverse primer shown in SEQ ID NO: 9, and the length of the amplified product is 204 bp;

[0017] The fourth primer pair includes a forward primer shown in SEQ ID NO: 3 and a reverse primer shown in SEQ ID NO: 10, and the length of the amplified product is 511 bp.

[0018] The present invention also discloses a primer pair combination for quantitatively detecting the size distribution of CHO cell DNA fragments, comprising at least three pairs of the primer pairs, more preferably comprising the first primer pair, the second primer pair and the fourth primer pair; or the first primer pair, the third primer pair and the fourth primer pair; or comprising the first primer pair, the second primer pair, the third primer pair and the fourth primer pair.

[0019] The present invention also discloses a kit for quantitatively detecting the size distribution of CHO cell DNA fragments, comprising the above primer pair or primer pair combination.

[0020] Preferably, a probe is also included.

[0021] Preferably, the nucleotide sequence of the probe is as shown in SEQ ID NO:15.

[0022] Preferably, one end of the probe is labeled with a fluorescent reporter group FAM, and the other end is labeled with a quencher group BHQ1.

[0023] The kit may also include other reagents required for qPCR detection, such as enzymes, buffers, etc.

[0024] The invention also discloses the use of the primer pair, primer pair combination or the kit in in vitro quantitative detection of CHO cell DNA fragment size distribution.

[0025] The present invention also discloses a method for quantitatively detecting the size distribution of CHO cell DNA fragments, using the above primer pair or primer pair combination as primers, performing qPCR on the sample to be tested, and detecting the qPCR amplification product; or using the above kit, performing qPCR on the sample to be tested, and detecting the qPCR amplification product.

[0026] Preferably, the sample to be tested is from any one of vaccines, recombinant protein drugs, and antibody drugs prepared based on CHO cell matrix cultivation.

[0027] The beneficial effects of the present invention are as follows:

[0028] (1) The purpose of the present invention is to provide a primer pair and reagent for quantitatively detecting CHO residual DNA fragments using real-time fluorescence quantitative PCR (real-time qPCR) technology, which can be used to analyze CHO residual DNA fragments in intermediates and finished products of biological products, which is conducive to improving the process, improving product quality, and being used for product quality control and release.

[0029] (2) The qPCR detection method using the primer probe is simple and quick to operate, and only takes 3 hours from obtaining the sample to giving the test report; it has high sensitivity, and the quantitative limit is 3fg / μL; it has strong specificity and can distinguish interfering DNA such as mouse genome, E. coli, MDCK cells, HEK293, Vero cells, and Pichia pastoris cells. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 Screening test plot for the first set of primers.

[0031] Figure 2 Screening test plots for the second set of primers.

[0032] Figure 3 Screening test plot for the third set of primers.

[0033] Figure 4 Screening test plot for the fourth set of primers.

[0034] Figure 5 This is the amplification curve of the standard curve of system 1.

[0035] Figure 6 This is the standard curve of system 1.

[0036] Figure 7 This is the amplification curve of the standard curve of system 2.

[0037] Figure 8 This is the standard curve of system 2.

[0038] Fig. 9 This is the amplification curve of the standard curve of system 3.

[0039] Fig.10 This is the standard curve diagram of system 3.

[0040] Fig.11 This is the amplification curve of the standard curve of system 4.

[0041] Fig.12 This is the standard curve diagram of system 4.

[0042] Fig.13 This is the amplification curve of the specificity test of system 1.

[0043] Fig.14 This is the amplification curve of the specificity test of system 2.

[0044] Fig.15 This is the amplification curve of the specificity test of system 3.

[0045] Fig.16 This is the amplification curve of the specificity test of system 4.

[0046] Fig.17 This is the amplification curve of the quantitative limit test of system 1.

[0047] Fig.18 This is the amplification curve of the quantitative limit test of system 2.

[0048] Fig.19 This is the amplification curve of the quantitative limit test of system 3.

[0049] Fig. 20 This is the amplification curve of the quantitative limit test of system 4. DETAILED DESCRIPTION

[0050] The specific implementation modes of the present invention are further described below in conjunction with the accompanying drawings, but the description of the embodiments does not impose any limitation on the protection scope of the present invention.

[0051] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by technicians in the technical field to which the present invention belongs. The terms used in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention.

[0052] Unless otherwise specified, the materials and instruments used in the following examples can be obtained from conventional commercial channels.

[0053] The primers of the present invention are the term "primers" used in the present invention as commonly understood by those skilled in the art. The CHO cell residual DNA specific primers of the present invention are not designed for the exogenous gene itself or the viral vector itself, but are designed for the sequence of CHO cell residual DNA as shown in SEQ ID NO: 1. In other words, the primers of the present invention can specifically bind to the sequence shown in SEQ ID NO: 1 of CHO cell genomic DNA.

[0054] In CHO genomic DNA, common repetitive sequences are short interspersed nuclear elements (SINE), i.e., Alu family sequences. Since ALU sequences in CHO genomic DNA are randomly distributed in large quantities in the genomic DNA, their copy number is large. Therefore, conventional detection of CHO DNA residues is mostly designed on this sequence for primer probes. However, this fragment is generally less than 200bp. It cannot meet the detection requirements of 200-300bp and 500bp. In order to meet the distribution of different sized fragments of CHO, the present invention selects another group of long interspersed sequences, i.e., LINE fragments (Long interspersed nuclear elements, SINE). The number of LINE sequence copies is less than that of SINE sequences, but they are also dispersed in large quantities in CHO genomic DNA. The average length of this sequence is greater than 1000bp, which can fully cover the detection requirements of 500bp fragments. An example of a sequence of a LINE fragment is shown in SEQ ID NO:1.

[0055] In view of the teachings of the present invention and the common knowledge in the art, it should be understood by those skilled in the art that a variety of primer pairs can be designed for the sequence shown in SEQ ID NO: 1. Therefore, the primer pairs of the present invention are not limited to the primer pairs specifically used in the embodiments. Selecting any section in the sequence based on the primers provided by the present invention, or truncating, extending, and replacing several nucleotides based thereon all belong to the concept of the present invention.

[0056] In a specific embodiment, SEQ ID NOs: 2 to 6 are forward primers.

[0057] The sequence shown in SEQ ID NO:2 is specifically: AAGTCAGGGATGGTGATGCC, which binds to the CHO cell genomic DNA

[0058] Positions 105-124 of the sequence shown in SEQ ID NO:1.

[0059] The sequence shown in SEQ ID NO:3 is specifically: AGAAGTTCCTTTATTGTATAGGGATG, which binds to positions 128-153 of the sequence shown in SEQ ID NO:1 on the genomic DNA of CHO cells.

[0060] The sequence shown in SEQ ID NO:4 is specifically: GATGGTGATGCCTCCAGAAG, which binds to positions 113-132 of the sequence shown in SEQ ID NO:1 on the genomic DNA of CHO cells.

[0061] The sequence shown in SEQ ID NO:5 is specifically: GGTCTACCAGTCTATTTTTGTGCCA, which binds to positions 37-61 of the sequence shown in SEQ ID NO:1 on the genomic DNA of CHO cells.

[0062] The sequence shown in SEQ ID NO:6 is specifically: CTTGAAGTCAGGGATGGTGATG, which binds to positions 101-122 of the sequence shown in SEQ ID NO:1 on the genomic DNA of CHO cells.

[0063] In a specific embodiment, SEQ ID NOs: 7 to 14 are reverse primers.

[0064] The sequence shown in SEQ ID NO:7 is specifically: TCACAGACCTTGAAAGAACAGT, which binds to positions 198-219 of the sequence shown in SEQ ID NO:1 on the genomic DNA of CHO cells.

[0065] The sequence shown in SEQ ID NO: 8 is specifically: CTTCACAGACCTTGAAAGAACAGTT, which binds to the CHO cell genome

[0066] Positions 197-221 of the sequence shown in SEQ ID NO: 1 on the DNA.

[0067] The sequence shown in SEQ ID NO:9 is specifically: AGGTAGGATCAACATAGTAAAAATGGC, which binds to positions 282-308 of the sequence shown in SEQ ID NO:1 on the genomic DNA of CHO cells.

[0068] The sequence shown in SEQ ID NO: 10 is specifically: CTCACTATTTGCAGACGATATGATAG, which binds to positions 613-638 of the sequence shown in SEQ ID NO: 1 on the genomic DNA of CHO cells.

[0069] The sequence shown in SEQ ID NO:11 is specifically: ACAGACCTTGAAAGAACAGTTCTC, which binds to positions 194-217 of the sequence shown in SEQ ID NO:1 on the genomic DNA of CHO cells.

[0070] The sequence shown in SEQ ID NO: 12 is specifically: CTCTTGGATAGGTAGGATCAACATAG, which binds to positions 292-317 of the sequence shown in SEQ ID NO: 1 on the genomic DNA of CHO cells.

[0071] The sequence shown in SEQ ID NO:13 is specifically: AAAGTGGCAGGATACAAGATTAACT, which binds to positions 526-550 of the sequence shown in SEQ ID NO:1 on the genomic DNA of CHO cells.

[0072] The sequence shown in SEQ ID NO: 14 is specifically: GAAAGGAAGAAGTCAAACTCTCAC, which binds to positions 634-657 of the sequence shown in SEQ ID NO: 1 on the genomic DNA of CHO cells.

[0073] The term "probe" described herein has the meaning commonly understood by those skilled in the art, ie, a short single-stranded DNA or RNA fragment used to detect a nucleic acid sequence complementary thereto.

[0074] In view of the teachings of the present invention and the common knowledge in the art, it should be understood by those skilled in the art that, knowing the primer pair, those skilled in the art can independently design the probe according to the template sequence between the forward primer and the reverse primer binding site, and detect the technical effect of the probe and the primer pair. In a specific embodiment, a person of ordinary skill in the art can specifically design the probe as needed, and the probe can be in a liquid phase or fixed on a solid phase; it can be combined before amplification or after amplification. Therefore, the probe of the present invention is not limited to the probe specifically disclosed in the embodiment. The primer pair of the present invention is also not limited to the use of paired with the probe specifically disclosed in the embodiment.

[0075] In a specific embodiment, the probe of the present invention has a sequence as shown in SEQ ID NO:15.

[0076] The sequence shown in SEQ ID NO: 15 is specifically: FAM-TGGCTATCCTGGGTCTTTTGTTTCTCC-BHQ1, which binds to positions 157-183 of the sequence shown in SEQ ID NO: 1 on the genomic DNA of CHO cells.

[0077] [Materials, instruments and methods used in the present invention]

[0078] 1. Materials

[0079] From Yisheng Biotechnology (Shanghai) Co., Ltd., including CHO qPCR buffer, DNA diluent, primer pairs of the present invention, probes of the present invention, and CHO DNA quantitative reference. The composition of the target sequence, primer pairs, and probes of the present invention are specifically shown in Table 1 below.

[0080] 2. Instruments

[0081] Applied biosystems 7500 fluorescence quantitative PCR instrument.

[0082] 3. Methods

[0083] 3.1 Standard curve sample preparation

[0084] The CHO DNA quantitative reference substance was diluted 10-fold with DNA diluent to prepare standard solutions of 300 pg / μL, 30 pg / μL, 3 pg / μL, 0.3 pg / μL, 0.03 pg / μL, and 0.003 pg / μL.

[0085] 3.2qPCR reaction system

[0086] Detection system 30μL: 20μL qPCR reaction solution + 10μL template.

[0087] The reaction program was set on the Applied biosystems 7500 fluorescence quantitative PCR instrument: pre-denaturation at 95°C for 5 min; 95°C for 15 s, 60°C for 1 min, 45 cycles; reaction volume was 30 μL.

[0088] 3.3 Data Analysis

[0089] After amplification, set the threshold line and read the amplification efficiency, slope, and R 2 As well as the detection value and Ct value of each sample.

[0090] 3.4 Result determination

[0091] 1) Correlation coefficient R of the standard curve equation 2 It should be greater than 0.990, with a slope between -3.1 and -3.7 (i.e., amplification efficiency between 90% and 110%);

[0092] 2) The Ct value of the target channel of the negative control no template control (NTC) and interfering DNA was not detected or ≥35.00, the Ct value of the internal standard channel was not affected, and the difference with the Ct value of the negative control no template control (NTC) was ≤1.

[0093] Example 1: Primer screening

[0094] Four groups of 12 primer combinations were amplified, threshold lines were drawn, and CT values ​​and fluorescence peaks were compared. The primer pair combinations are shown in Table 1, and the screening test results are shown in Table 1. Figure 1-4 As shown. The results show that the first primer pair 1, the second primer pair 1, the third primer pair 1, and the fourth primer pair 1 have high fluorescence peaks before the CT value. Therefore, the first primer pair 1, the second primer pair 1, the third primer pair 1, and the fourth primer pair 1 are selected as the preferred primer pairs for each system. The results of the four primer screening tests are shown in Table 2. The primer pairs and probes are combined to obtain several different systems as shown in Table 3 below.

[0095] Table 1: Different primer pair combinations

[0096]

[0097] Table 2. Results of four primer screening tests

[0098]

[0099] Table 3 Combinations of four different fragment detection systems

[0100] Combination Product size System 1 SEQ ID NO:3, SEQ ID NO:7, SEQ ID NO:15 92bp System 2 SEQ ID NO:2, SEQ ID NO:8, SEQ ID NO:15 117bp System 3 SEQ ID NO:2, SEQ ID NO:9, SEQ ID NO:15 204bp System 4 SEQ ID NO:3, SEQ ID NO:10, SEQ ID NO:15 511bp

[0101] Example 2: Linear range

[0102] The standard curve was amplified using four different fragment detection systems, and the standard curve correlation coefficient (R 2 ) and amplification efficiency. The results showed that the linear range of the four different fragment detection systems established was 300pg / μL~30fg / μL, and the standard curve R 2 ≥0.990, Eff (amplification efficiency) is 90%-110%, NTC Ct value is ≥35.00, and internal quality control signal Ct value is ≤27.00.

[0103] The amplification curves and linear relationship diagrams of the standard curves of system 1 to system 4 are shown in the figure below. Figures 5 to 12 As shown, Table 4 is a table of linear range test results of four different fragment detection systems.

[0104] Table 4. Linear range test results of four different fragment detection systems

[0105]

[0106] Example 3: Specificity

[0107] The interference of genomic DNA of six cells / bacteria commonly used in production of engineered cell genomes, MDCK, E. coli, HEK293, VERO, Pichia pastoris, and Mouse, on the detection system of different CHO fragments was evaluated. Specifically, the test samples were genomic DNA of the above six cells / bacteria at a concentration of 300pg / μL. The genomic DNA of the above six cells / bacteria was used as a template, and the reaction system was 20μL qPCR reaction solution + 10μL template. The amplification primers and probes used for each test sample were system 1 to system 4 in Table 3, respectively. And internal quality control was added to each reaction solution.

[0108] The results showed that none of the six selected detection target signals interfering with genomic DNA were detected, the difference between the internal quality control signal and NTC was ≤1, and the internal quality control was not affected. This ruled out the situation of non-detection due to sample inhibition. This shows that it has little interference with the four established systems and the system shows better specificity. The amplification curve of the specificity test is shown in Figure 13-16 As shown, Table 5 is a table of specificity test results of four different fragment detection systems.

[0109] Table 5. Specificity test results of four different fragment detection systems

[0110]

[0111]

[0112] Example 4: Limit of Quantitation

[0113] The standard curves of four different fragment detection systems (300pg / μL to 3fg / μL) were amplified, and the detection Ct values ​​of each group at a template amount of 3fg / μL (10 replicates) were measured at the same time. The detection Ct values ​​were substituted into the standard curve to calculate the detection concentration of each well, and the coefficient of variation (CV) and deviation of the detection concentration of 10 replicates were calculated. The results showed that the CV and deviation of the 3fg / μL detection concentration of each system were ≤20.0%, and the quantitative limit was 3fg / μL. The amplification curves of the quantitative limit test were as follows: Figure 17-20 The quantitative limit detection results are shown in Table 6.

[0114] Table 6 Quantitation limit detection results

[0115]

[0116] Example 5: Testing of real samples with different primer pair combinations

[0117] In the four systems in Example 1, two different primer pair combinations were randomly selected for quantitative detection of the size distribution of CHO cell DNA fragments. Combination 1 includes system 1, system 2 and system 4, and combination 2 includes system 1, system 2, system 3 and system 4. These two combinations were used to perform qPCR detection on samples produced by multiple CHO cells, and the DNA content of fragments of different lengths in the same sample was analyzed. The experimental results are shown in Table 7 below. The experimental results show that the DNA content in different samples is different; for the same sample, the detection values ​​of amplified fragments of different lengths are also different. However, these samples all have one characteristic: the amplified fragment is short, and its DNA detection value is high; the amplified fragment is long, and its DNA detection value is low. This is consistent with the actual situation.

[0118] Table 7 Quantitation limit detection results

[0119]

[0120]

[0121] The present invention illustrates the detailed method of the present invention through the above-mentioned embodiments, but the present invention is not limited to the above-mentioned detailed method, that is, it does not mean that the present invention must rely on the above-mentioned detailed method to be implemented. Those skilled in the art should understand that any improvement of the present invention, equivalent replacement of various raw materials of the product of the present invention, addition of auxiliary components, selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.

Claims

1. A primer pair for quantitatively detecting the size distribution of CHO cell DNA fragments, characterized in that: At least one set of primer pairs described below is included: the forward primer and the reverse primer in each primer pair specifically bind to the segment shown in SEQ ID NO: 1, respectively, and the length of the amplification product of one set of primer pairs is less than 100 bp, the length of the amplification product of one set of primer pairs is 100-199 bp, the length of the amplification product of one set of primer pairs is 200-500 bp, and the length of the amplification product of one set of primer pairs is more than 500 bp.

2. The primer pair according to claim 1, characterized in that The primer pair refers to the first primer pair, the second primer pair, the third primer pair or the fourth primer pair; The forward primer of the first primer pair binds to positions 113-156 of the sequence shown in SEQ ID NO: 1; the reverse primer binds to positions 184-221 of the sequence shown in SEQ ID NO: 1, and the length of the amplified product of the primer pair is 90-98 bp; The forward primer of the second primer pair binds to positions 101-156 of the sequence shown in SEQ ID NO: 1; the reverse primer binds to positions 184-221 of the sequence shown in SEQ ID NO: 1, and the length of the amplified product of the primer pair is 105-120 bp; The forward primer of the third primer pair binds to positions 101-156 of the sequence shown in SEQ ID NO: 1; the reverse primer binds to positions 282-320 of the sequence shown in SEQ ID NO: 1, and the length of the amplification product of the primer pair is 200-220 bp; The forward primer of the fourth primer pair binds to positions 37-153 of the sequence shown in SEQ ID NO: 1; the reverse primer binds to positions 526-638 of the sequence shown in SEQ ID NO: 1, and the length of the amplified product of the primer pair is 500-557 bp.

3. The primer pair according to claim 2, characterized in that: The first primer pair includes a forward primer shown in SEQ ID NO: 3 and a reverse primer shown in SEQ ID NO: 7; The second primer pair includes a forward primer shown in SEQ ID NO: 2 and a reverse primer shown in SEQ ID NO: 8; The third primer pair includes a forward primer shown in SEQ ID NO: 2 and a reverse primer shown in SEQ ID NO: 9; The fourth primer pair includes a forward primer shown in SEQ ID NO: 3 and a reverse primer shown in SEQ ID NO:

10.

4. A primer pair combination for quantitatively detecting the size distribution of CHO cell DNA fragments, characterized in that: The method comprises at least three of the primer pairs described in claim 2 or 3.

5. The primer pair combination according to claim 4, characterized in that: The method comprises the first primer pair, the second primer pair and the fourth primer pair in claim 2 or 3; or comprises the first primer pair, the third primer pair and the fourth primer pair in claim 2 or 3; or comprises the first primer pair, the second primer pair, the third primer pair and the fourth primer pair in claim 2 or 3.

6. A kit for quantitatively detecting the size distribution of CHO cell DNA fragments, characterized in that The method comprises the primer pair described in any one of claims 1 to 3, or the primer pair combination described in claim 4 or 5.

7. The kit according to claim 6, characterized in that A probe is also included.

8. The kit according to claim 7, characterized in that The nucleotide sequence of the probe is shown in SEQ ID NO:

15.

9. Use of a product for in vitro quantitative detection of DNA fragment size distribution in CHO cells, wherein the product is a primer pair as described in any one of claims 1 to 3, or a primer pair combination as described in claim 4 or 5, or a kit as described in any one of claims 6 to 8.

10. A method for quantitatively detecting the size distribution of CHO cell DNA fragments, characterized in that: Using the primer pair described in any one of claims 1 to 3 or the primer pair combination described in claim 4 or 5 as primers, qPCR is performed on the sample to be tested, and the qPCR amplification product is detected; or using the kit described in any one of claims 6 to 8, qPCR is performed on the sample to be tested, and the qPCR amplification product is detected.

Citation Information

Cited By

  • CHO cell residual DNA detection method and application thereof

    CN120310930A